Oriflame executive acquires shares in company
Oriflame chairman Robert af Jochnick has increased his slice of the direct sales cosmetics business by acquiring a further 80,000 shares.
The deal brings the executives total number of shares in the business to over three million, which gives him a 5.5 per cent share in both voting rights and business capital.
Back in December 2009 the company founder divested one million shares in the business as a means of divesting in other investment interests, including health care company Medicover.
In 2010 Oriflame announced that sales were 8 per cent in local currencies to €1.51bn, while net profits rose by rose 26 per cent to reach €128.3m.
![Study involving over 6,000 subjects says sensitisation rate of propylene glycol was 'infrequent'. [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/cosmetics/cosmeticsdesign-asia.com/headlines/formulation-science/propylene-glycol-sensitisation-found-to-be-uncommon-australia-study/16401110-1-eng-GB/Propylene-glycol-sensitisation-found-to-be-uncommon-Australia-study.jpg)
